Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 943-080-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin irritation study (OECD 439): not irritating to skin
Eye corrosion study (OECD 437): not corrosive to eyes
Eye irritation study (OECD 405): not irritating to eyes
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 19-22 May 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study in compliance with EU-Method B.46 resp. OECD guideline 439
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- GLP compliance:
- yes (incl. QA statement)
- Species:
- human
- Strain:
- other: human skin model EpiDermTM
- Amount / concentration applied:
- 25 mg on average
- Duration of treatment / exposure:
- 60 minutes
- Number of animals:
- 3 epidermic tissue
- Details on study design:
- This in-vitro study was performed in order to evaluate the potential of SABOSTAT A 300 to evoke skin irritation in a human-skin-model.
The test consists of a topical exposure of the neat test item to a human reconstructed epi-dermis model followed by a cell viability test. Cell viability is measured by dehydrogenase conversion of MTT (= 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide), pre-sent in cell mitochondria, into a blue formazan salt that is quantitatively measured after extraction from tissues. The percentage reduction of cell viability in comparison of untreat-ed negative controls is used to predict skin irritation potential. - Irritation / corrosion parameter:
- other: other: Optical Density percentage with respect to negative control
- Value:
- 119.6
- Remarks on result:
- other:
- Remarks:
- Basis: mean. (migrated information)
- Interpretation of results:
- not irritating
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The test item is considered as not skin irritant.
After the treatment, the relative absorbance values were increased to 119.6%. This value is well above the threshold for skin irritation (50%).
The optical density of the negative control (mean OD = 1.8) was well within the required acceptability criterion of 0.8 ≤ mean OD ≤ 2.8. The positive control induced a decrease in the relative absorbance as compared to the negative control to 2.8 % (required: 20%) for thus ensuring the validity of the test system. Variation within replicates was within the accepted range for negative control, positive control and test item.
For these reasons, the result of the test is considered valid. - Executive summary:
3 tissues of the human skin model EpiDermTMwere treated with the substance for 60 min. On average, 25 mg of the solid test item (wetted with 25 µL DPBS-buffer) were applied to each tissue and spread to match the tissue size (0.63 cm2; as indicated by supplier). DPBS-buffer was used as negative control, 5 % SDS solution was used as positive control. After treatment with the negative control, the absorbance values were within the required acceptability criterion of 0.8 ≤ mean OD ≤ 2.8, OD was 1.8. The positive control showed clear irritating effects. Relative absorbance was reduced to 2.8 %. Variation within tissues was acceptable (< 18%). After the treatment with the test item, the relative absorbance values were increased to 119.6%. This value is well above the threshold for irritation potential (50%). Therefore,the substance is considered as not skin irritant in the Human Skin Model Test.
Reference
Findings and Results
Measured Values
As blank, the optical density of isopropanol was measured in eight wells of the 96-well-plate. The measured values and their mean are given in the following table:
Absorbance values blank isopropanol (OD at 570 nm)
Replicate |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
Mean |
Absorbance |
0.038 |
0.037 |
0.037 |
0.038 |
0.036 |
0.037 |
0.037 |
0.037 |
0.037 |
The absorbance values of negative control, test item and positive control are given in the following table:
Absorbance Values negative control, test item and positive control (OD at 570 nm)
Designation |
Measurement |
Negative Control |
SABOSTAT A 300 |
Positive Control |
Tissue 1 |
1 |
1.828 |
2.320 |
0.088 |
2 |
1.794 |
2.250 |
0.085 |
|
Tissue 2 |
1 |
1.786 |
1.999 |
0.083 |
2 |
1.780 |
1.980 |
0.083 |
|
Tissue 3 |
1 |
1.877 |
2.235 |
0.089 |
2 |
1.840 |
2.215 |
0.089 |
From the measured absorbances, the mean of each tissue was calculated, subtracting the mean absorbance of isopropanol as given in table above. Mean and relative standard deviation (comparison of the 3 tissues) were also calculated.
Mean Absorbance Values
Designation |
Negative Control |
SABOSTAT A 300 |
Positive Control |
Mean – blank (tissue 1) |
1.774 |
2.248 |
0.050 |
Mean – blank (tissue 2) |
1.746 |
1.953 |
0.046 |
Mean – blank (tissue 3) |
1.822 |
2.188 |
0.052 |
Mean of the 3 tissues |
1.781 |
2.130 |
0.049 |
Relative standard deviation |
2.2% |
7.3% |
6.2% |
Comparison of Formazan Production
For the test item and the positive control, the following percentage values of formazan production were calculated in comparison to the negative control:
% Formazan Production
Designation |
SABOSTAT A 300 |
Positive Control |
% Formazan production (tissue 1) |
126.2% |
2.8% |
% Formazan production (tissue 2) |
109.7% |
2.6% |
% Formazan production (tissue 3) |
122.9% |
2.9% |
% Formazan production (mean) |
119.6% |
2.8% |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation
- Remarks:
- in vitro
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 15 July 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study according to international guidelines.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- Qualifier:
- according to guideline
- Guideline:
- other: OECD Guidelines for the Testing of Chemicals, adopted 25. Jul. 2014, DRAFT PROPOSAL FOR A NEW TEST GUIDELINE , Reconstructed Human Cornea-like Epithelium (RhCE)
- Qualifier:
- according to guideline
- Guideline:
- other: “EpiOcular TM Eye Irritation Test (OCL-200-EIT) for the prediction of acute ocular irri-tation of chemicals” by MatTek Corporation, document no. MK‐24‐007‐0055, dated 10. Dec. 2012
- GLP compliance:
- yes (incl. QA statement)
- Species:
- other: 3D human cornea tissue model
- Strain:
- not specified
- Details on test animals or tissues and environmental conditions:
- Commercially available EpiOcularTM kit.
The EpiOcularTM tissue consists of normal, human-derived keratinocytes which have been cultured to form a stratified squamous epithelium similar to that found in the human cornea. It consists of highly organized basal cells. These cells are not transformed or transfected with genes to induce an extended life span. The EpiOcularTM tissues are cultured in specially prepared cell culture inserts with a porous membrane through which nutrients can pass to the cells. The tissue surface is 0.6 cm2.
EpiOcularTM tissues were procured from MatTek In Vitro Life Science Laboratories, Mylnské Nivy 73, 82105 Bratislava, Slovakia.
Day of delivery: 14. Jul. 2015
Batch no.: 21562 - Vehicle:
- unchanged (no vehicle)
- Controls:
- other: negative and positive control vessels (in vitro study)
- Amount / concentration applied:
- The following amounts were applied to the tissues:
Tissue 1 51.5 mg
Tissue 2 49.4 mg - Duration of treatment / exposure:
- 6 hours
- Observation period (in vivo):
- Not applicable
- Number of animals or in vitro replicates:
- Not applicable
- Irritation parameter:
- other: Relative absorbance (%)
- Basis:
- mean
- Score:
- 107.5
- Remarks on result:
- other: Absorbance of test item compared to negative control
- Interpretation of results:
- not irritating
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of the test system, the substance is considered as
not eye irritant in the EpiOcularTM Eye Irritation Test.
After treatment with the test item, the relative absorbance values increased to 107.5 %.
This value is well above the threshold for eye irritation potential (60%).
All validity criteria were met. The criterion for optical density of the negative control was fulfilled: The OD value was 1.3 (> 1.0 and < 2.6).
The positive control induced a decrease in the relative absorbance as compared to the negative control to 32.1% (< 60%). Variation within the replicates was acceptable (<20 %).
For these reasons, the result of the test is considered as valid. - Executive summary:
The substance was applied to a three-dimensional human cornea tissue model in duplicate for a 6 h exposure.
In average, 50.5 mg of the solid test item were applied to each tissue.
After treatment, the respective substance was rinsed from the tissue; then, cell viability of the tissues was evaluated by addition of MTT which can be reduced to a blue formazan. Formazan production was measured by measuring the optical density (OD) of the resulting solution.
Deionised water was used as negative control, Methyl acetate was used as positive control.
The controls showed the expected results. After treatment with the negative control, the absorbance values were within the required acceptability criterion of 1.0 ≤ mean OD ≤ 2.6, OD was 1.3. The positive control showed clear eye irritating effects, the relative absorbance value was reduced to 32.1 %. Variation within tissues was acceptable (< 20%).
After treatment with the test item, the relative absorbance values increased to 107.5 %.
This value is well above the threshold for eye irritation potential (60%).
Under the conditions of the test system, the substance is considered as
not eye irritant in the EpiOcularTMEye Irritation Test.
Reference
Findings and Results
Measured Values
As blank, the optical density of isopropanol was measured in eight wells of the 96-well-plate. The measured values and their mean are given in the following table:
Table 1.Absorbance Values Blank Isopropanol (OD at 570 nm)
Replicate |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
Mean |
Absorbance |
0.035 |
0.038 |
0.035 |
0.035 |
0.034 |
0.036 |
0.036 |
0.036 |
0.036 |
The absorbance values of negative control, test item and positive control are given in the following table:
Table 2. Absorbance Values Negative Control, Positive Control and Test Item (OD at 570 nm)
Designation |
Measurement |
Negative Control |
Positive Control |
SABOSTAT A 300 |
Tissue 1 |
1 |
1.289 |
0.453 |
1.440 |
2 |
1.368 |
0.457 |
1.438 |
|
Tissue 2 |
1 |
1.358 |
0.456 |
1.446 |
2 |
1.360 |
0.456 |
1.447 |
From the measured absorbances, the mean of each tissue was calculated, subtracting the mean absorbance of isopropanol as given in table 1 (= corrected values).
Table3 Mean Absorbance Negative Control, Positive Control and Test Item
Designation |
Negative Control |
Positive Control |
SABOSTAT A 300 |
Mean – blank (Tissue 1) |
1.293 |
0.419 |
1.403 |
Mean – blank (Tissue 2) |
1.323 |
0.420 |
1.411 |
Comparison of Formazan Production
For the test item and the positive control, the following percentage values of formazan production were calculated in comparison to the negative control:
Table 4 % Viability Positive Control and Test Item
Designation |
Positive Control |
SABOSTAT A 300 |
% Viability (Tissue 1) |
32.0% |
107.3% |
% Viability (Tissue 2) |
32.1% |
107.8% |
% Viability Mean |
32.1% |
107.5% |
Assessment
Eye irritation is assessed using the criteria given in the following table (source: MatTek Corporation):
Table 5 Assessment of Eye Irritation
% Viability |
Assessment |
GHS classification |
> 60 % |
Non eye irritant |
No GHS category |
≤60 % |
Eye irritant |
GHS category 1 or 2 |
Validity
Validity criteria and results are stated in the following table:
Table 6 Validity
Criterion |
Demanded |
Found |
OD of negative control |
≥1.0 and≤ 2.6 |
1.3 |
% Formazan production of positive control |
< 60% of negative control |
32.1% |
Variation within replicates |
< 20% |
2.3% (negative control) |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Three tissues of the human skin model EpiDermTMwere treated with the substance for 60 min.On average, 25 mg of the solid test item (wetted with 25 µL DPBS-buffer) were applied to each tissue and spread to match the tissue size (0.63 cm2; as indicated by supplier).DPBS-buffer was used as negative control, 5 % SDS solution was used as positive control.After treatment with the negative control, the absorbance values were within the required acceptability criterion of 0.8 ≤ mean OD ≤ 2.8, OD was 1.8. The positive control showed clear irritating effects. Relative absorbance was reduced to 2.8 %.Variation within tissues was acceptable (< 18%). After the treatment with the test item, the relative absorbance values were increased to 119.6%. This value is well above the threshold for irritation potential (50%). Therefore,the substance is considered as not skin irritant in the Human Skin Model Test.
The substance was applied to a three-dimensional human cornea tissue model in duplicate for a 6 h exposure.
In average, 50.5 mg of the solid test item were applied to each tissue.
After treatment, the respective substance was rinsed from the tissue; then, cell viability of the tissues was evaluated by addition of MTT which can be reduced to a blue formazan. Formazan production was measured by measuring the optical density (OD) of the resulting solution.
Deionised water was used as negative control, Methyl acetate was used as positive control.
The controls showed the expected results. After treatment with the negative control, the absorbance values were within the required acceptability criterion of 1.0 ≤ mean OD ≤ 2.6, OD was 1.3. The positive control showed clear eye irritating effects, the relative absorbance value was reduced to 32.1 %. Variation within tissues was acceptable (< 20%).
After treatment with the test item, the relative absorbance values increased to 107.5 %.
This value is well above the threshold for eye irritation potential (60%).
Under the conditions of the test system, the substance is considered as
not eye irritant in the EpiOcularTMEye Irritation Test.Justification for classification or non-classification
No evidence of adverse effects in 3 reliable (Klimisch 1) in vitro studies for skin irritation (OECD 439), for eye corrosion (BCOP, OECD 437) and eye irritation (EPIocular, OECD 405).
Thus the substance can be considered not irritant according to CLP regulation
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.